Develops, manufactures, and markets pharmaceutical treatments for opioid use disorders
Inflation Reduction Act of 2022, PL 117-169 and FY 2023 Consolidated Appropriations Act, PL 117-318 (in both cases issues related to pharmaceutical treatments for opioid use disorders). Proposals relating to substance abuse disorders and serious mental illnesses, including substance abuse treatment in correctional facilities via telehealth. S.3393,SUPPORT for Patients and Communities Reauthorization Act. S.2309, HEAL Act.
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 37 - Justice, Dept of (DOJ) 1 - SENATE 12 - White House Office
PUTALASTRATEGIES
3015 Dumbarton Street, NW, Washington, DC, 20007, US
CHRISTOPHER PUTALA